STOCK TITAN

Electromed (NYSE: ELMD) adds $10M secured revolving credit facility

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Electromed, Inc. entered into a new Credit Agreement with BMO Bank N.A., providing a senior secured revolving credit facility of $10,000,000. The facility matures on December 16, 2026, and any borrowings will bear interest at one-month Term SOFR plus 1.75%, payable monthly.

The company granted a first-priority security interest in substantially all existing and future assets and agreed to customary covenants, indemnities, and events of default. While amounts are outstanding, Electromed must maintain a minimum Fixed Charge Coverage Ratio of at least 1.20x and a Total Funded Debt to EBITDA ratio of not more than 2.50x, calculated quarterly on a rolling four-quarter basis. Proceeds may be used for capital expenditures, working capital, and general corporate purposes, and the prior credit facility with Choice Financial Group was terminated.

Positive

  • None.

Negative

  • None.
false 0001488917 0001488917 2025-12-16 2025-12-16
DMS_US.374923169.2
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
     
 
FORM 8-K 
     
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): December 16, 2025
     
 
ELECTROMED, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Minnesota
001-34839
41-1732920
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(I.R.S. Employer Identification
Number)
 
500 Sixth Avenue NW
New Prague, MN 56071
(Address of Principal Executive Offices) (Zip Code)
 
(952) 758-9299
(Registrant’s Telephone Number, Including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Common Stock, $0.01 par value
 
ELMD
 
NYSE American LLC
(Title of each class)
 
(Trading Symbol)
 
(Name of each exchange on which registered)
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Item 1.01
Entry into a Material Definitive Agreement.
 
On December 16, 2025, Electromed, Inc. (the “Company”) entered a Credit Agreement (the “Credit Agreement”) with BMO Bank N.A. (“Lender”), as lender. The Credit Agreement provides the Company with a senior security credit facility with a $10,000,000 revolving line of credit (the “Credit Facility”). The Credit Agreement provides that the Credit Facility will mature on December 16, 2026. Any borrowings under the Credit Facility will bear interest at one-month Term SOFR plus 1.75%, payable monthly.
 
The Company provided a first priority security interest in substantially all of its existing and future assets to secure the payment obligations under the Credit Agreement. The Credit Agreement contains certain customary covenants that limit the Company’s ability to engage in certain transactions. The Credit Agreement also contains customary indemnification obligations and events of default, including, among other things, (i) non-payment, (ii) non-performance of covenants and obligations, (iii) default on other indebtedness, (iv) judgments, (v) misrepresentation and (vi) bankruptcy and insolvency. The Company may use the proceeds of the Credit Facility to finance capital expenditures and for working capital and general corporate purposes.
 
In addition, at any time that there is any borrowing under the Credit Facility, the Company is subject to certain financial covenants, including maintaining a minimum Fixed Charge Coverage Ratio of at least 1.20x and a Total Funded Debt to EBITDA (as each such term is defined in the Credit Agreement) ratio of not more than 2.50x, each calculated on a quarterly basis over a rolling four-quarter period.
 
The foregoing description of the Credit Facility is qualified by reference to the text of the Credit Agreement, a copy of which is attached as Exhibits 10.1 and incorporated herein by reference. 
 
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
 
In connection with the execution of the Credit Facility described in response to Item 1.01 of this Current Report on Form 8-K, the Company terminated its existing credit facility with Choice Financial Group.
 
Item 9.01
Financial Statements and Exhibits.
 
 
(d) Exhibits:
 
Exhibit Number
 
Description
10.1
 
Credit Agreement, dated as of December 16, 2025, between the Company, as borrower, and BMO Bank N.A., as lender*
104
 
Cover Page Interactive Data File (embedded in the cover page and formatted in inline XBRL)
*Certain exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted exhibit can be furnished to the SEC upon request.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ELECTROMED, INC.
     
Date: December 18, 2025
By:
/s/ Bradley M. Nagel
 
Name:
Bradley M. Nagel
 
Title:
Chief Financial Officer
 
 
 
 

FAQ

What new credit facility did Electromed (ELMD) establish with BMO Bank N.A.?

Electromed entered into a Credit Agreement with BMO Bank N.A. for a senior secured $10,000,000 revolving credit facility that can be drawn as needed up to the limit.

When does Electromed’s new $10,000,000 revolving credit facility mature?

The revolving credit facility provided by BMO Bank N.A. to Electromed matures on December 16, 2026.

What interest rate applies to Electromed’s borrowings under the new credit agreement?

Any borrowings under the Credit Facility will bear interest at one-month Term SOFR plus 1.75%, with interest payable monthly.

What collateral secures Electromed’s new credit facility with BMO Bank N.A.?

Electromed granted a first priority security interest in substantially all of its existing and future assets to secure its obligations under the Credit Agreement.

What financial covenants must Electromed (ELMD) maintain under the new credit facility?

While any amounts are borrowed, Electromed must maintain a Fixed Charge Coverage Ratio of at least 1.20x and a Total Funded Debt to EBITDA ratio of not more than 2.50x, measured quarterly over a rolling four-quarter period.

How will Electromed use the proceeds from the new BMO Bank N.A. credit facility?

Electromed may use proceeds from the Credit Facility to finance capital expenditures and for working capital and general corporate purposes.

What happened to Electromed’s prior credit facility with Choice Financial Group?

In connection with entering into the new Credit Facility with BMO Bank N.A., Electromed terminated its existing credit facility with Choice Financial Group.
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Latest SEC Filings

ELMD Stock Data

192.90M
6.56M
21.3%
53.31%
3.37%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE